Pablo Cerezuela

Murcia, MU, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Murcia, MU, ES 

Overview

Pablo Cerezuela practices practicing medicine in Murcia, Spain.

His clinical expertise encompasses Melanoma, Neuroendocrine Tumor, Venous Thromboembolism (VTE), and Congenital Aplastic Anemia.

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Murcia, MU, Spain
Other Locations
30120, Spain
El Palmar, MU, Spain
Cartagena, MU, Spain
Madrid, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Other
An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors [IGNYTE]
An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors [IGNYTE]
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2026
Intervention Type: Biological
Study Drugs: RP1, Nivolumab
Study Phase: Phase 2
Phase II, Multicentre Clinical Trial to Evaluate the Activity of Encorafenib and Binimetinib Administered Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Phase II, Multicentre Clinical Trial to Evaluate the Activity of Encorafenib and Binimetinib Administered Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug, Radiation
Study Drugs: Encorafenib, Binimetinib
Study Phase: Phase 2
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Biological, Drug
Study Drugs: Cemiplimab, RP1
Study Phase: Phase 2
A Randomized Phase II Study of Vemurafenib Plus Cobimetinib Continuous Versus Intermittent, in Previously Untreated BRAFV600- Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
A Randomized Phase II Study of Vemurafenib Plus Cobimetinib Continuous Versus Intermittent, in Previously Untreated BRAFV600- Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

12 Total Publications

Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.
Journal: The oncologist
Published: June 13, 2024

Frequently Asked Questions about Pablo Cerezuela

Is Pablo Cerezuela a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Pablo Cerezuela is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pablo Cerezuela participate in research or clinical trials?

Yes. Pablo Cerezuela has published 12 articles and abstracts on conditions like Melanoma. You can view a list of Pablo Cerezuela's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cerezuela's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile